![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
5 min
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
Trials and PIs with Dr Michael Gibson #14: FUTURA OASIS 8 with Dr Sanjit Jolly Trials and PIs with Dr Michael Gibson
-
- Science
Dr Sanjit Jolly (McMaster University, Hamilton, ON) discusses FUTURA OASIS 8: a randomized trial comparing two regimens of adjunctive intravenous unfractionated heparin during PCI in high-risk patients with non-STE-ACS treated with fondaparinux.
Recorded at the ESC convention center in Stockholm, Sweden on Tuesday, August 31.
Dr Sanjit Jolly (McMaster University, Hamilton, ON) discusses FUTURA OASIS 8: a randomized trial comparing two regimens of adjunctive intravenous unfractionated heparin during PCI in high-risk patients with non-STE-ACS treated with fondaparinux.
Recorded at the ESC convention center in Stockholm, Sweden on Tuesday, August 31.
5 min